Topical resiquimod 0.01% gel decreases herpes simplex virus type 2 genital shedding: a randomized, controlled trial.
Mark KE, Corey L, Meng TC, Magaret AS, Huang ML, Selke S, Slade HB, Tyring SK, Warren T, Sacks SL, Leone P, Bergland VA, Wald A.
Mark KE, et al. Among authors: magaret as.
J Infect Dis. 2007 May 1;195(9):1324-31. doi: 10.1086/513276. Epub 2007 Mar 16.
J Infect Dis. 2007.
PMID: 17397003
Clinical Trial.